| India |
|---|
| Novel Formulation of Alpha KetoanalogueRef. Number: 324347(dtd. 01 Dec, 2019) | Patent application no.1154/MUM/2011(dtd.06 Dec, 2011) |
| Tolvaptan (API)IntermediateRef. Number: 304391(dtd. 13 Dec, 2018) | Patent application no.3295/MUM/2013(dtd.21 Dec, 2013) |
| Clopidogrel Bisulphate form 1 API processRef. Number: 298954(dtd. 18 Dec, 2018) | Patent application no.758/MUM/2010(dtd.22 Dec, 2010) |
| S(+) clopidogrel free base processRef. Number: 252835(dtd. 04 Dec, 2012) | Patent application no.836/MUM/2005(dtd.12 Dec, 2005) |
| Pantoprazole sodium sesquihydrate API processRef. Number: 238641(dtd. 15 Dec, 2010) | Patent application no.551/MUM/2005(dtd.04 Dec, 2005) |
| Lamotrigine Dispersible & Meltable Tablet processRef. Number: 219025(dtd. 21 Dec, 2008) | Patent application no.419/MUM/2004(dtd.06 Dec, 2004) |
| Cyclosporine formulation processRef. Number: 203188(dtd. 07 Dec, 2006) | Patent application no.254/MUMNP/2003(dtd.24 Dec, 2003) |
| Risperidon API processRef. Number: 196155(dtd. 04 Dec, 2005) | Patent application no.IN/PCT/2002/01520/MUM(dtd.30 Dec, 2002) |
